Avinger (NASDAQ:AVGR) and ABIOMED (NASDAQ:ABMD) Head to Head Analysis – Mitchell Messenger

Avinger (NASDAQ:AVGR) and ABIOMED (NASDAQ:ABMD) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Avinger and ABIOMED, as provided by MarketBeat.com.

Institutional & Insider Ownership

13.1% of Avinger shares are held by institutional investors. Comparatively, 90.7% of ABIOMED shares are held by institutional investors. 0.5% of Avinger shares are held by company insiders. Comparatively, 3.4% of ABIOMED shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Avinger and ABIOMEDs net margins, return on equity and return on assets.

Risk & Volatility

Avinger has a beta of 1.74, meaning that its share price is 74% more volatile than the S&P 500. Comparatively, ABIOMED has a beta of 0.32, meaning that its share price is 68% less volatile than the S&P 500.

Valuation & Earnings

This table compares Avinger and ABIOMEDs top-line revenue, earnings per share (EPS) and valuation.

ABIOMED has higher revenue and earnings than Avinger. Avinger is trading at a lower price-to-earnings ratio than ABIOMED, indicating that it is currently the more affordable of the two stocks.

Summary

ABIOMED beats Avinger on 11 of the 13 factors compared between the two stocks.

Avinger Company Profile

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.

ABIOMED Company Profile

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; and Impella RP, a percutaneous catheter-based axial flow pump. In addition, the company is involved in the development of Impella 5.5 and Impella BTR that are percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump, a device for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Japan. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.

Read more:

Avinger (NASDAQ:AVGR) and ABIOMED (NASDAQ:ABMD) Head to Head Analysis - Mitchell Messenger